1 INTRODUCTION     

   1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights
    4.1 Overview of the Market
    4.2 Geographic Analysis of the Market
    4.3 Market, By Type
    4.4 Market, By End User
    4.5 Market, By Application
    4.6 Geographic Snapshot of the Market

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Rising Prevalence of Cancer
                    5.3.1.2 Increasing Adoption of Digital Pathology to Enhance Lab Efficiency
                    5.3.1.3 Growing Application of Digital Pathology in Drug Development and Companion Diagnostics
                    5.3.1.4 Ease of Consultation Enabled By Digital Pathology
                    5.3.1.5 Increasing Initiatives By Governments and Industry Players
                    5.3.1.6 Increasing Number of Research Projects Establishing the Efficacy of Digital Pathology
           5.3.2 Restraints
                    5.3.2.1 High Cost of Digital Pathology Systems
                    5.3.2.2 Regulatory Concerns
                    5.3.2.3 Lack of Standard Guidelines
                    5.3.2.4 Reluctance Among Pathologists to Adopt Advanced Technologies
           5.3.3 Opportunities
                    5.3.3.1 Digital Pathology to Help Combat the Shortage of Pathologists
                    5.3.3.2 Introduction of Affordable Scanners for Private Pathology Practices
                    5.3.3.3 Personalized Medicine to Open Array of Opportunities
                    5.3.3.4 Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
                    5.3.3.5 Increasing Digital Pathology Initiatives in Asia
    5.4 Regulatory Implications
           5.4.1 Health Insurance Portability and Accountability Act (HIPAA)
           5.4.2 Food and Drug Administration (FDA)
           5.4.3 Clinical Laboratory Improvement Amendments (CLIA)

6 Digital Pathology Market, By Product
    6.1 Introduction
    6.2 Scanners
    6.3 Software
    6.4 Communication Systems
    6.5 Storage Systems

7 Digital Pathology Market, By Type
    7.1 Introduction
    7.2 Human Digital Pathology
    7.3 Animal Digital Pathology

8 Digital Pathology Market, By End User
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies and Cro’s
    8.3 Hospitals and Reference Laboratories
    8.4 Academic & Government Research Institutes

9 Digital Pathology Market, By Application
    9.1 Introduction
    9.2 Teleconsultation
    9.3 Disease Diagnosis
    9.4 Drug Discovery
    9.5 Training and Education

10 Global Digital Pathology Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the U.S.
                        10.2.1.2 Rising Cancer Prevalence in the U.S.
                        10.2.1.3 De Novo Application By the FDA
             10.2.2 Canada
                        10.2.2.1 Growing Need for Quality Cancer Diagnosis in Canada
                        10.2.2.2 Implementation of Favorable Initiatives By Canadian Authorities
     10.3 Europe
             10.3.1 EU-5
                        10.3.1.1 Initiatives Adopted By Nhs England Promoting the Adoption of Digital Pathology in the U.K.
                        10.3.1.2 Technological Developments in the U.K. Market
                        10.3.1.3 Organization of Digital Pathology-Related Conferences in the U.K.
                        10.3.1.4 Organization of Digital Pathology-Related Conferences in Germany
                        10.3.1.5 Successful Digital Pathology Projects in Italy
                        10.3.1.6 Active Involvement of Industry Players to Augment the Demand for Digital Pathology in France
                        10.3.1.7 Implementation of Digital Pathology-Related Projects to Drive Market Growth in Spain
             10.3.2 RoE
                        10.3.2.1 High Cancer Prevalence to Boost Market Growth in Denmark
                        10.3.2.2 Norway: Conferences and Industry Collaborations in the Regional Market
                        10.3.2.3 Increased Investments By Government Bodies in Sweden
                        10.3.2.4 Digital Pathology Gaining Momentum in the Netherlands
     10.4 Asia-Pacific
             10.4.1 China
                        10.4.1.1 Industry Initiatives to Boost Digital Pathology Market in China
                        10.4.1.2 Favorable Initiatives for the Adoption of Telepathology in China
             10.4.2 Japan
                        10.4.2.1 Initiatives By Nec for Cancer Diagnosis to Propel the Market in Japan
             10.4.3 India
                        10.4.3.1 Focus of Market Players on India
             10.4.4 RoAPAC
                        10.4.4.1 Cancer Control Initiatives in Australia
                        10.4.4.2 Approvals for Digital Pathology Solutions in South Korea, Partnerships Between Local and Global Players
     10.5 RoW
             10.5.1 Potential for the Growth of Digital Pathology in Africa
             10.5.2 Increasing Focus By Industry Players and Academic Institutes on the Brazilian Market
             10.5.3 Increasing Focus of Industry Players on Organic Growth Strategies in the Middle East

11 Competitive Landscape
     11.1 Overview
     11.2 Competitive Situation and Trends
             11.2.1 Agreements, Collaborations, and Partnerships
             11.2.2 Product Launches
             11.2.3 Client Acquisitions
             11.2.4 Expansions
             11.2.5 Acquisitions
             11.2.6 Other Strategies

12 Company Profiles
     12.1 Introduction
     12.2 Leica Biosystems Nussloch GMBH (Subsidiary of Danaher Corp)
     12.3 Ventana Medical Systems, Inc. (Member of Roche Group)
     12.4 Hamamatsu Photonics K.K.
     12.5 3dhistech Ltd.
     12.6 Philips Healthcare
     12.7 Apollo Enterprise Imaging Corp. (Formerly Apollo Pacs, Inc.)
     12.8 Xifin, Inc.
     12.9 Definiens AG
     12.10 Visiopharm A/S
     12.11 Omnyx, LLC (Venture By Ge Healthcare and UPMC)
     12.12 Corista LLC